Validation of New Tools for the Assessment of Cognitive Functions and Connectivity Network in Hypertensive Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-02-28

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The relationship among hypertension, aging and cognitive decline is complex and not completely understood. Purpose of this project will be evaluating early markers of cognitive deterioration in patients with arterial hypertension. In particular, this cross-sectional observational study will be articulated in three phases:

1. Neuropsychological evaluation of general cognitive abilities
2. Identification and measurement of specific biomarker levels
3. Correlation among hypertension, cognitive abilities and biomarkers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

DETECT and Retinal Outcomes in Hypertension

NCT01815567

Hypertension Retinal Disorder Cognitive Impairment

COMPLETED

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study

NCT06897670

Major Depressive Disorder Bipolar Disorder Mild Cognitive Impairment

RECRUITING

Study of Social Cognition Processes With Multimodal MRI on Healthy Adult Patients.

NCT06164964

Social Cognition

COMPLETED

Evaluation of Essential Metal Metabolism

NCT06911515

Disturbance of Consciousness Alteration of Metabolism Essential Metals

ACTIVE_NOT_RECRUITING

Brain Injury and Cognitive Function

NCT05922748

Cerebral Lesion Cognitive Deficit Following Brain Lesions

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Hypertensive

No interventions assigned to this group

2

Normotensive

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males or females diagnosed with arterial hypertension between 40 and 65 years of age;
* Written informed consent prior to enrollment in the study.

Exclusion Criteria

* Precedent acute myocardial infarction (AMI);
* Previous stroke and/or transient ischemic attack (TIA);
* Previous or concomitant neurologic or psychiatric pathologies;
* Neurologic or psychiatric pharmacological therapy.

Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No